USPTO serial 79277929
Reviewed by CopyMark Law Group
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Plus Government fees of $975
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Anna Kurian Shaw
Anna Kurian Shaw Hogan Lovells US LLP555 13th Street NWWashington, DC 20004UNITED STATES| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Medical and pharmaceutical products, namely, pharmaceutical preparations for the treatment of oncological, anti-viral, anti-bacterial and autoimmunity disorders and diseases and natural remedy preparations for the treatment of oncological, viral, bacterial and autoimmunity disorders and diseases; diagnostic reagents for medical purposes; synthetic peptides, binding proteins and living cells for medical, diagnostic and therapeutic purposes, in particular for cancer therapy | ACTIVE | — |
| 042 | Medical research and pharmacological research services; conducting research and clinical trials for others relating to the use and the engineering of t-cells and cancer treatment and therapy; scientific research in the field of chemistry, biochemistry and biology; scientific laboratory services, namely, biological, biochemical and chemical laboratory services; biological, biochemical and chemical analysis; medical and scientific research in the field of cancer diagnosis; scientific laboratory services, namely, biological and biochemical laboratory services; biological and biochemical research, development and analysis services | ACTIVE | — |
| 044 | Medical services and pharmaceutical services, namely, medical diagnosis and medical diagnosis through the use of pharmacologicals of oncological, viral, bacterial, and autoimmune diseases; dispensing of pharmaceuticals, namely, providing medical supply for therapy, in particular supply of synthetic peptides, binding proteins and living cells for cancer therapy; medical diagnosis of cancer | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 27, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Aug 6, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Mar 23, 2026 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Nov 2, 2022 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Nov 2, 2022 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Nov 2, 2022 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 2, 2022 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Nov 2, 2022 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Oct 7, 2022 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jul 18, 2021 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jun 29, 2021 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jun 29, 2021 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jun 23, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Mar 23, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 10, 2021 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jan 5, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 5, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 23, 2020 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Dec 23, 2020 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Dec 16, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 1, 2020 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Dec 1, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 24, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 24, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 24, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 29, 2020 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 29, 2020 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 29, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 7, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 7, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 6, 2020 | ALIE | ASSIGNED TO LIE | — |
| Aug 28, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 14, 2020 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Aug 14, 2020 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Aug 14, 2020 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 14, 2020 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Aug 14, 2020 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| May 28, 2020 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Mar 21, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 4, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 4, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Feb 14, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Feb 11, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Feb 10, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 10, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 10, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 6, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |